As messenger substances, interferons stimulate various responses of immune cells and play a key role in activating the immune system. They are proven active agents against various diseases, especially type I interferon alpha ...
Feb 14, 2022
0
36
Hepatitis C can now be effectively treated, thanks to modern drugs. However, despite having been cured, some patients can go on to develop liver cancer. Currently, biannual ultrasound screening is done to monitor for incipient ...
Jan 28, 2022
0
16
An analysis was carried out on a cohort of 1,000 patients from 11 Andalusian hospitals. The project underscores the need for personalized medicine and individual evaluation of patients with hepatitis C, even after recovering ...
Jan 27, 2022
0
8
A new test for hepatitis C which uses origami-style folded paper to deliver fast, accurate and affordable diagnoses could help the global fight against the deadly virus.
Nov 30, 2021
0
28
In a new cohort study of patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), a disease with a high recurrence rate, researchers at the Osaka City University Graduate School of Medicine reported that ...
Nov 24, 2021
0
5
Ontarians with chronic hepatitis C can lose up to 20 percent of their overall income managing their condition, a new study has found.
Nov 1, 2021
0
9
Hepatitis C virus (HCV) infection can lead to long-term health problems including liver damage, liver failure, cirrhosis, liver cancer and even death. These outcomes are especially dangerous for pregnant people and their ...
Oct 29, 2021
0
30
Researchers at the Medical University of South Carolina (MUSC) report in the Journal of Viral Hepatitis that the activity levels of the proteins involved in liver scarring, or cirrhosis, begin to decrease immediately after ...
Oct 26, 2021
0
5
A new national report released today highlights a decline in hepatitis C testing and treatment uptake, putting Australia at risk of not achieving its target of eliminating hepatitis C as a public health threat by 2030.
Oct 25, 2021
0
4
Nineteen months into the pandemic, the need for antiviral drugs targeted against COVID-19 is clear, given the global persistence of the virus, its ability to rapidly mutate into new variants and the possibility that it could ...
Oct 22, 2021
0
14
